Quantcast

Latest Esophageal cancer Stories

2014-03-26 08:28:35

Supplemental approval will expand PDT with Photofrin® treatments in specific lung and esophageal cancers TORONTO AND BANNOCKBURN, IL, March 26, 2014 /PRNewswire/ - Concordia Healthcare Corp. (Concordia or the Company) (TSX:CXR) (OTCQX: CHEHF) announced today that its subsidiary Pinnacle Biologics, Inc. (Pinnacle), a biopharmaceutical research and development company specializing in rare diseases, was granted U.S. Food and Drug Administration (FDA) premarket supplemental...

2014-03-22 20:20:22

Data presented at the Latest in Dermatology Research Symposia session of 72nd Annual Meeting of the American Academy of Dermatology DENVER, March 22, 2014 /PRNewswire/ -- Castle Biosciences Inc. today announced study results showing its gene expression profile (GEP) test (DecisionDx-Melanoma) can identify primary cutaneous (skin) melanoma tumors that are likely to metastasize in patients who had a negative sentinel lymph node biopsy. The data are being presented at the Latest in...

2014-02-24 12:26:21

Non-Surgical Procedure Offers Patients Significant Improvement in Symptoms and Elimination or Reduction in Medication, Along With a Regression of Barrett's Metaplasia NORWALK, Conn., Feb. 24, 2014 /PRNewswire/ -- A newly-published peer-reviewed clinical study evaluated 217 patients pre-treatment and tracked them for ten years after receiving Stretta Therapy to treat gastroesophageal reflux disease (GERD). The study, entitled "Long-term maintenance effect of radiofrequency energy delivery for...

2014-02-06 16:31:34

DUBLIN, February 6, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/jl6rp5/2013_russia) has announced the addition of the "Concise Analysis of the International Russian Procedure Volumes Database" [http://www.researchandmarkets.com/research/jl6rp5/2013_russia ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This in-depth procedure volumes database quantifies current and forecast...

2014-02-06 16:27:09

DUBLIN, February 6, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/dlgvhh/2013_brazil) has announced the addition of the "2013 Brazil Procedure Volumes Database" [http://www.researchandmarkets.com/research/dlgvhh/2013_brazil ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) In 2010, 14 million surgical procedures were performed in Brazil, and more than two-thirds of them were provided...

2014-02-06 16:23:19

DUBLIN, February 6, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/zg5tp2/2013_china ) has announced the addition of the "Concise Analysis of the International Chinese Procedure Volumes Database" [http://www.researchandmarkets.com/research/zg5tp2/2013_china ] directory to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Forecasts suggest a robust 9.8% CAGR* in China, with each individual medical...

2014-02-04 12:27:40

Program goal is improved understanding of individual risk for recurrence in patients diagnosed with early stage melanoma FRIENDSWOOD, Texas, Feb. 4, 2014 /PRNewswire/ -- Castle Biosciences Inc., a leading developer of diagnostic and prognostic tests for rare cancers, today announced the launch of an educational program dedicated to the information needs of Stage I and II skin (cutaneous) melanoma patients and their caregivers. The program kicks off with the launch of an animated...

2014-01-16 08:27:06

Enables physicians and patients to proactively avoid toxicities from treatments unlikely to provide benefit SAN FRANCISCO, Jan.16, 2014 /PRNewswire/ -- Castle Biosciences today announced that study results of a proprietary predictive test for esophageal cancer demonstrated strong accuracy and specificity in identifying patients who are likely to have tumors that are extremely resistant to standard pre-surgical treatment of chemotherapy and radiation. Data from this second...

2014-01-07 08:32:28

Collaboration will provide Cernostics with access to one of the largest Barrett's Esophagus patient registries in the world PITTSBURGH, Jan. 7, 2013 /PRNewswire/-- Cernostics, a diagnostics company focused on delivering next generation cancer diagnostics through a unique approach to tissue analysis, announced today that it is collaborating with the Academic Medical Center in The Netherlands (AMC). As part of the collaboration, AMC will be providing Cernostics with access to one of...

2014-01-06 23:02:34

In-demand research study “Monoclonal Antibodies Market in Gastric and Esophageal Cancers to 2019 - Crowded Late-Stage Pipelines and Favorable Market Conditions Encourage Robust Growth” worked out by GBI Research has been recently published by Market Publishers Ltd. According to the study, the value of the overall market for mAbs in gastric and esophageal cancers is forecast to touch the USD 766 million mark by 2019. London, UK (PRWEB) January 06, 2014 Currently, esophageal and gastric...


Latest Esophageal cancer Reference Libraries

Gastroscopy
2013-03-04 10:13:56

The esophagogastroduodenoscopy is a medical diagnostic procedure used in internal medicine to view the upper part of the gastrointestinal tract. This non-invasive procedure is used for many complaints and requires little to no time for recovery from the procedure. Reasons for the Procedure Patients present to their physician with physical complaints. For example, a patient may come into the office and say they have been feeling tired and forgetful. Through many tests and evaluations,...

More Articles (1 articles) »
Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related